Cuba vs Ukraine: Death rate from Parkinson's disease
Cuba
6.77 deaths per 100,000 people
in 2021
Ukraine
7.09 deaths per 100,000 people
in 2021
Cuba rank
45th
Ukraine rank
43rd
Death rate from Parkinson's disease over time
- Cuba
- Ukraine
How they compare
Ukraine currently reports 7.09 deaths per 100,000 people against 6.77 deaths per 100,000 people in Cuba, a difference of 0.32 deaths per 100,000 people.
Across all 22 years both countries report, Ukraine has been ahead every year.
Cuba ranks 45th and Ukraine ranks 43rd of 194 countries.
Ukraine has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.68 deaths per 100,000 people | 5.83 deaths per 100,000 people | 3.15 deaths per 100,000 people | Ukraine |
| 2010s | 4.8 deaths per 100,000 people | 6.7 deaths per 100,000 people | 1.9 deaths per 100,000 people | Ukraine |
| 2020s | 6.53 deaths per 100,000 people | 7.11 deaths per 100,000 people | 0.58 deaths per 100,000 people | Ukraine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from parkinson's disease, Cuba or Ukraine?
- Ukraine, at 7.09 deaths per 100,000 people against 6.77 deaths per 100,000 people in Cuba as of 2021.
- What is the difference in death rate from parkinson's disease between Cuba and Ukraine?
- 0.32 deaths per 100,000 people, with Ukraine ahead.
- How many years of comparable data are there for Cuba and Ukraine?
- 22 years are reported by both, from 2000 to 2021.
- How do Cuba and Ukraine rank globally for death rate from parkinson's disease?
- Cuba ranks 45th and Ukraine ranks 43rd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Death rate from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes, per 100,000 people.